BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 29, 2014
View Archived Issues
Caspase-6 miRNA improves Huntington's disease manifestations in a mouse model
Read More
New irreversible pan-FGFR inhibitors with high in vivo activity against FGFR-dependent cancers
Read More
Synthetic Biologics reports topline results from phase Ia trial of SYN-004
Read More
Sevion forms antibody discovery collaboration with Janssen
Read More
MacroGenics enters collaboration agreement with Janssen to develop MGD-011
Read More
Achillion reports results from two studies of HCV regimen
Read More
NEURON BioPharma patents new neuroprotective statins
Read More
VBL Therapeutics reports phase IIa data for VB-111 in recurrent thyroid cancer
Read More
Celgene begins phase III study of apremilast in patients with active Behcet's disease
Read More
Kite Pharma submits IND application for phase I/II trial of KTE-C19
Read More
Repurposing study suggests potential of known compounds against EBV
Read More
Abbott completes acquisition of medical device company
Read More
Tekmira authorized to start phase I trial of RNAi therapeutic for HBV infection
Read More
Tiziana Life Sciences licenses anti-CD3 monoclonal antibody from NovImmune
Read More
Bio-Path to begin development of liposomal Bcl-2 in follicular lymphoma
Read More
Ferroportin shows promising data as a biomarker for multiple myeloma
Read More
BARDA provides funding to speed development of NewLink/Merck & Co. Ebola vaccine
Read More
Acturum Life Science reports development of gamma-secretase modulators
Read More
FDA approves Namzaric for Alzheimer's disease
Read More
Sorrento Therapeutics develops anti-PD-1 MAbs
Read More
Biogen Idec reports chimeric FVII-XTEN-anti-GPIIb/IIIa molecules
Read More
GSK divulges EZH2 inhibitors
Read More
FDA grants emergency use authorization for LightMix Ebola Zaire rRT-PCR Test
Read More
Safinamide NDA resubmitted to FDA
Read More
FDA issues complete response letter for Actavis' nebivolol/valsartan NDA
Read More